Table 4.
Therapeutic Window/Benefits of Flavonoids | Plant | Patent Number | Reference | |
---|---|---|---|---|
1. | Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancers. |
Cannabis sativa L. | US20180098961A1 |
[93] |
2. | Agent containing flavonoid derivatives for treating cancer and inflammation. |
Cannabis sativa L. | US20170360744A1 | [94] |
3. | Therapeutic agents containing cannabis flavonoid derivative for ocular disorders. |
Cannabis sativa L. | US10278950B2 | [95] |
4. | Therapeutic agents containing cannabis flavonoid derivatives for the prevention and treatment of neurodegenerative disorders. | Cannabis sativa L. | US10751320B2 | [96] |
5. | Pi 4-kinase inhibitor as a therapeutic for viral hepatitis, cancer, malaria. autoimmune disorders and inflammation, and a radiosensitizer and immunosuppressant. |
Vernonia acuminata DC. |
WO2018022868A1 | [97] |
6. | Therapeutic antiviral agents containing cannabis cannabinoid derivatives. |
Cannabis sativa L. | US20180214389A1 | [98] |
7. | Methods for inhibiting HIV-1 activity by inhibitory mechanisms of extracts of Guaiacum officinale L. (Zygophyllaceae) | Guaiacum officinale L. | US9814747B2 | [99] |
8. | Therapeutic potential of dibenzyl trisulfide Isolated from Petiveria alliacea L. (Guinea Hen Weed, Anamu) | Petiveria alliacea L. | Patent pending | [45,100] |